Merck’s Bio-Techne acquisition strengthens fundamentals yet stock price appears fairly valued now

Merck strengthens its life sciences portfolio with Bio-Techne, but analyst consensus suggests investors should wait for a better entry point.
Strategies for acquiring new customers

Merck strengthens its life sciences portfolio with Bio-Techne, but analyst consensus suggests investors should wait for a better entry point.

Acquisition offers represent a fundamental inflection point for scientific and technology startups: they can accelerate innovation timelines by years,...

Scientific software companies are experiencing unprecedented valuation levels as acquisition discussions intensify across the sector.

Pepper, a technology platform serving independent food distributors, has acquired Alima, a Y Combinator-backed artificial intelligence startup,...

Pepper's March 2026 acquisition of Y Combinator-backed Alima represents a significant strategic move that strengthens the company's position in AI-driven...

Beijing's answer is clear and restrictive: tech founders can be barred from leaving China during acquisition negotiations, particularly when geopolitical...

In 2025 and early 2026, pharmaceutical shareholders have received notably favorable prices in major acquisitions, with deal premiums ranging from 24% to...

Child-friendly robots are attracting corporate acquisition interest because they represent a rare convergence of consumer demand, technological viability,...

When a celebrity purchases a historic property at a significant price, the expectation often follows: the value should appreciate over time.